NMSEAM: Advances in MS... Join us at 4:30 p.m. Eastern, 3:30 p.m. Central, 2:30 p.m. Mountain, 1:30 p.m. Pacific, on March 10, for /Events/MSF-Events/2026/March/NMSEAM-Advances-in-MS-Treatment-A-40-Year-Perspe

Transportation Assista... Helping members remain as independent as possible, and ensuring all people with MS have the... /Get-Help/MSF-Programs-Grants/Transportation-Assistance-Grant

Life with MS

.

Life with MS

Life with MS

With patience, trial and error, and the assistance of our resources, we have learned how to make travel a little less challenging. And it’s worth it!

Study suggests fenebrutinib’s potential as BTK Inhibitor

March 03, 2026

Phase III results show benefits for treating both relapsing and primary...

Spending bill to curtail practices of pharmacy middlemen

February 19, 2026

Change would require PBMs to pass through 100 percent of rebates to...

Fenebrutinib reduces disability progression in primary progressive MS

February 10, 2026

Phase III results show investigational fenebrutinib met primary endpoint...

NMSEAM: Advances in MS Treatment: A 40-Year Perspective

Join us at 4:30 p.m. Eastern, 3:30 p.m. Central, 2:30 p.m. Mountain, 1:30 p.m. Pacific, on March 10, for NMSEAM: Advances in MS Treatment: A 40-Year Perspective, presented by Dr. Ben Thrower. Register at msfocus.us/Thrower0326.

Join us at 4:30 p.m. Eastern, 3:30 p.m. Central, 2:30 p.m. Mountain, 1:30 p.m. Pacific, on March ...

Learn More Learn More